Cynthia Arbeeny

Chief Scientific Officer at Mitotherapeutix

Role
Chief Scientific Officer at Mitotherapeutix
Location
Boston, MA, US
LinkedIn followers
500 followers
Research & DevelopmentView LinkedIn profile

About Cynthia Arbeeny

Biopharmaceutical industry professional providing expertise and strategy to organizations and executive teams to build and advance their portfolio of novel therapies focused on acquired and rare metabolic diseases.• Extensive experience within the pharmaceutical, biotechnology and academic sectors• Broad experience across all functional areas of biopharma R&D• In-depth knowledge and experience in the metabolic diseases space: diabetes and associated co-morbidities (obesity, cardiovascular and diabetic kidney disease (DKD), non-alcoholic steatohepatitis (NASH) and fibrosis, rare metabolic and kidney diseasesAreas of Expertise:• Provide strategic direction for early stage target identification, drug discovery, preclinical R&D, and clinical development• Contribute to business development strategy, support due diligence efforts and external partnering• Provide competitive assessment and positioning of new therapies

Experience

  1. Chief Scientific Officer

    Mitotherapeutix

    Dec 2020 — Present · Boston, MA, US

    Mitotherapeutix was created to take advantage of advancements in RNA chemistry and its use in developing siRNA based drugs that can target otherwise difficult to address disease targets. Our first target is DNAJC15, a gene that is responsible for the production of a peptide MCJ (Methylation Controlled J Protein), which is an endogenous mitochondrial repressor. We have explored the function of this metabolic regulator in different tissues and disease states and have found that turning off the regulator can have a positive effect in disease treatment. Our initial focus is in liver disease (NASH and acute liver injury), kidney disease (polycystic kidney disease and acute kidney injury), and immuno- related cancer/CD8 T-cells.

Education

  • Rutgers University

    PhD, Physiology

  • Albert Einstein College of Medicine

    Postdoctoral Fellow, Lipoprotein Metabolism, Diabetes, Liver Physiology

Skills

  • R&D
  • Endocrinology
  • Pharmaceutical Industry
  • Pharmacology
  • Dyslipidemia
  • Lifesciences
  • Cardiovascular Disease
  • Life Sciences
  • Clinical Trials
  • Pharmaceutics
  • Drug Discovery
  • Metabolism
  • Clinical Development
  • Medicine
  • Technology Transfer
  • Commercialization
  • Biotechnology
  • Research and Development (R&D)
  • Biopharmaceuticals

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Cynthia Arbeeny — Chief Scientific Officer at Mitotherapeutix in Boston, MA, US | Unifers